Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative Outcome Analysis of Lenvatinib Versus Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
Magyar CTJ, Perera S, Rajendran L, Li Z, Almugbel FA, Feng S, Choi WJ, Aceituno L, Vogel A, Grant RC, Selzner N, Jaeckel E, Falla-Rad N, Knox JJ, Chen EX, Sapisochin G, O'Kane GM. Magyar CTJ, et al. Among authors: selzner n. Transplantation. 2024 Nov 6. doi: 10.1097/TP.0000000000005240. Online ahead of print. Transplantation. 2024. PMID: 39531339
Temporal evolution of living donor liver transplantation survival-A United Network for Organ Sharing registry study.
Magyar CTJ, Li Z, Aceituno L, Claasen MPAW, Ivanics T, Choi WJ, Rajendran L, Sayed BA, Bucur R, Rukavina N, Selzner N, Ghanekar A, Cattral M, Sapisochin G. Magyar CTJ, et al. Among authors: selzner n. Am J Transplant. 2024 Aug 18:S1600-6135(24)00497-0. doi: 10.1016/j.ajt.2024.08.011. Online ahead of print. Am J Transplant. 2024. PMID: 39163907
The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study.
Gorgen A, Galvin Z, Huang AC, Vinaixa C, O'Rourke JM, Francoz C, Hansen BE, Durand F, Elsharkawy AM, Shah T, Berenguer M, Rubin A, Calatayud D, Mehta N, Terrault NA, Lilly LB, Selzner N, Sapisochin G. Gorgen A, et al. Among authors: selzner n. Transplantation. 2020 Oct;104(10):2087-2096. doi: 10.1097/TP.0000000000003115. Transplantation. 2020. PMID: 31978002
Pursuing living donor liver transplantation improves outcomes of patients with autoimmune liver diseases: An intention-to-treat analysis.
Jones O, Claasen MPAW, Ivanics T, Choi WJ, Gavaria F, Rajendran L, Ghanekar A, Hirschfield G, Gulamhusein A, Shwaartz C, Reichman T, Sayed BA, Selzner M, Bhat M, Tsien C, Jaeckel E, Lilly L, McGilvray ID, Cattral MS, Selzner N, Sapisochin G. Jones O, et al. Among authors: selzner m, selzner n. Liver Transpl. 2024 Aug 1;30(8):785-795. doi: 10.1097/LVT.0000000000000374. Epub 2024 Apr 16. Liver Transpl. 2024. PMID: 38619393
The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation.
Aravinthan AD, Fateen W, Doyle AC, Venkatachalapathy SV, Issachar A, Galvin Z, Sapisochin G, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Grant DR, Selzner N, Lilly LB, Renner EL, Bhat M. Aravinthan AD, et al. Among authors: selzner m, selzner n. Transplantation. 2019 Dec;103(12):2523-2530. doi: 10.1097/TP.0000000000002757. Transplantation. 2019. PMID: 30985734
207 results